Crystallographic evidence for doxorubicin binding to the receptor-binding site in Clostridium botulinum neurotoxin B.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Acta Crystallographica Section D: Biological Crystallography

• Publication date

  2001-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1107/S0907444901013531PMID 11679763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of novel small molecule ligands that bind to tetanus toxin.

  2000influential reference
• Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B

  2000cited by this paper
• Neurotoxins affecting neuroexocytosis.

  2000cited by this paper
• Crystallization and preliminary X-ray analysis of Clostridium botulinum neurotoxin type B.

  2000cited by this paper
• Crystal structure of botulinum neurotoxin type A and implications for toxicity

  1998cited by this paper
• Integrated software for a macromolecular crystallography synchrotron beamline.

  1998cited by this paper
• Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity

  1998cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• Identification of a Ganglioside Recognition Domain of Tetanus Toxin Using a Novel Ganglioside Photoaffinity Ligand*

  1997cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• [33] AMoRe: An automated molecular replacement program package.

  1997influential reference
• Interaction between botulinum neurotoxin type A and ganglioside: ganglioside inactivates the neurotoxin and quenches its tryptophan fluorescence.

  1997cited by this paper
• Structure of the receptor binding fragment HC of tetanus neurotoxin

  1997cited by this paper
• Bacterial protein toxins penetrate cells via a four‐step mechanism

  1994cited by this paper
• Tetanus and Botulinum Neurotoxins Are Zinc Proteases Specific for Components of the Neuroexocytosis Apparatus a

  1994cited by this paper
• Molecular mechanisms of action of bacterial protein toxins.

  1994cited by this paper
• SNAP receptors implicated in vesicle targeting and fusion

  1993cited by this paper
• Interactions between morpholinyl anthracyclines and DNA. The crystal structure of a morpholino doxorubicin bound to d(CGTACG).

  1993cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• A program to produce both detailed and schematic plots of protein structures

  1991cited by this paper
• Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons

  1991cited by this paper
• RIBBONS 2.0

  1991cited by this paper
• Improved methods for building protein models in electron density maps and the location of errors in these models.

  1991cited by this paper
• Molecular pharmacology of botulinum toxin and tetanus toxin.

  1986cited by this paper
• How do tetanus and botulinum toxins bind to neuronal membranes

  1986cited by this paper

• Coumarin-based Strategies for Breast Cancer: A Multifaceted Perspective.

  2025cites this paper
• Role of radical quenching activity of dihydrocanaric acid in the treatment of cancer-experimental and theoretical

  2020cites this paper
• Targeted 8-hydroxyquinoline fragment based small molecule drug discovery against neglected botulinum neurotoxin type F.

  2019cites this paper
• High level expression and immunochemical characterization of botulinum neurotoxin type F light chain.

  2018cites this paper
• Crystal structure and conformational analysis of doxorubicin nitrate

  2018influential citation
• Challenges in searching for therapeutics against Botulinum Neurotoxins

  2017cites this paper
• Two Feet on the Membrane: Uptake of Clostridial Neurotoxins.

  2017cites this paper
• pH-controlled doxorubicin anticancer loading and release from carbon nanotube noncovalently modified by chitosan: MD simulations.

  2016cites this paper
• micelles and stabilize micellar structure shell interface of PEGylated phospholipid - coreamphiphilic drugs self-assemble to the

  2014cites this paper
• Current strategies for designing antidotes against botulinum neurotoxins

  2014cites this paper
• Molecular Aspects of Botulinum Neurotoxin

  2014cites this paper
• The Dual-Receptor Recognition of Botulinum Neurotoxins

  2014cites this paper
• Cationic amphiphilic drugs self-assemble to the core–shell interface of PEGylated phospholipid micelles and stabilize micellar structure

  2013cites this paper
• Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.

  2013cites this paper
• The entry of tetanus and botulinum neurotoxins into neurons

  2013cites this paper
• Structure and activity of Clostridium botulinum neurotoxin functional fragments

  2012cites this paper
• METAL ION-MEDIATED INACTIVATION AND SMALL MOLECULE INHIBITION OF THE METALLOPROTEASE IN BOTULINUM NEUROTOXIN A

  2012cites this paper
• Forensic Aspects of Biological Toxins

  2011cites this paper
• Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.

  2011cites this paper
• Molecular structures and functional relationships in clostridial neurotoxins

  2011cites this paper
• Botulinum neurotoxin: a marvel of protein design.

  2010cites this paper
• Light Chain Separated from the Rest of the Type A Botulinum Neurotoxin Molecule Is the Most Catalytically Active Form

  2010cites this paper
• Conformational diversity of anthracycline anticancer antibiotics: A density functional theory calculation

  2010cites this paper
• Receptor and substrate interactions of clostridial neurotoxins.

  2009cites this paper
• Bimodal modulation of the botulinum neurotoxin protein-conducting channel

  2009cites this paper
• Defense Against Biological Weapons (Biodefense)

  2009cites this paper
• Cell entry strategy of clostridial neurotoxins

  2009influential citation
• Advances in mapping of B cell epitope

  2009cites this paper
• Chapter 2 – Molecular Structures and Functional Relationships of Botulinum Neurotoxins

  2009cites this paper
• Chapter 4 – Interactions Between Botulinum Neurotoxins and Synaptic Vesicle Proteins

  2009cites this paper
• Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins

  2008cites this paper
• Conformational Changes in Small Ligands Upon Tetanus Toxin Binding

  2008cites this paper
• Identification of Protein Fold Topology Shared between Different Folds Inhibited by Natural Products

  2007cites this paper
• Antimicrobial Peptides: New Recognition Molecules for Detecting Botulinum Toxins

  2007cites this paper
• Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.

  2007cites this paper
• Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

  2007cites this paper
• Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A.

  2006cites this paper
• Application of NMR Methods to Identify Detection Reagents for Use in the Development of Robust Nanosensors in Protein Nanotechnology : Protocols

  2006cites this paper
• Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity

  2006cites this paper
• Forensic Aspects of Biologic Toxins

  2005cites this paper
• Medical Defense Against Protein Toxin Weapons

  2005cites this paper
• The evolving field of biodefence: therapeutic developments and diagnostics

  2005cites this paper
• Common binding site for disialyllactose and tri‐peptide in C‐fragment of tetanus neurotoxin

  2005cites this paper
• Application of NMR methods to identify detection reagents for use in development of robust nanosensors.

  2005cites this paper
• N-terminal helix reorients in recombinant C-fragment of Clostridium botulinum type B.

  2005cites this paper
• Protein Nanotechnology

  2005cites this paper
• Toward therapeutics for clostridium botulinum neurotoxins

  2004cites this paper
• Synaptotagmins I and II Act as Nerve Cell Receptors for Botulinum Neurotoxin G*

  2004cites this paper
• Medical aspects of biologic toxins.

  2004cites this paper
• Screening Mixtures of Small Molecules for Binding to Multiple Sites on the Surface Tetanus Toxin C Fragment by Bioaffinity NMR

  2002cites this paper
• Identification of novel small molecules that bind to two different sites on the surface of tetanus toxin C fragment.

  2002cites this paper